Acquired immunodeficiency syndrome (AIDS) is an often fatal disease caused by a retrovirus frequently resulting in malignancy and/or opportunistic infection. Because the immune deficiency in AIDS is similar to that in some purine enzyme deficiencies, we measured erythrocyte adenosine deaminase (ADA) and purine nucleoside phosphorylase activities in patients with AIDS, heterosexual controls, and a high-risk asymptomatic population. We found that erythrocyte ADA activity was significantly elevated in patients with AIDS (40 ± 11 nmol/mg of hemoglobin per hr, mean ± SD) relative to heterosexual controls (25 ± 10, P < 0.001). We also measured ADA activity in a group of individuals at high risk for AIDS and found that approximately half had significantly elevated ADA activities (45 ± 4, P < 0.002) that correlated with the presence of antibody to the lymphadenopathy retrovirus. Purine nucleoside phosphorylase activity was relatively normal in patients with AIDS as well as in individuals at risk for AIDS. Increased ADA appears to be a diagnostic marker of AIDS and may be useful in conjunction with antibody to the AIDS-related retrovirus in detecting the presence of infection in asymptomatic high-risk individuals. These data also suggest that, in addition to the lymphocyte, the erythroid cell line may also be infected by the AIDS-related retrovirus.
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Acquired immunodeficiency syndrome (AIDS) was first recognized 5-6 years ago (1, 2) . It is characterized by severe T-cell dysfunction and polyclonal hypergammaglobulinemia associated with life-threatening opportunistic infections, malignancies such as Kaposi sarcoma, and a variety of other clinical and laboratory manifestations (3, 4) . The infectious etiology of AIDS is a retrovirus (5-7). The AIDS-associated retrovirus [human T-cell lymphotropic virus type III (HTLV-III), lymphadenopathy virus (LAV)] has an affinity for the T-helper/inducer subpopulation of lymphocytes, although other cell types, for example monocytes, can be infected (8) .
The clinical and laboratory manifestations of AIDS are similar to those seen in children with inborn errors of purine metabolism, specifically adenosine deaminase (ADA) or purine nucleoside phosphorylase (PNP) deficiencies (9 (11, 12) .
Anti-Lymphadenopathy Virus (LAV) Antibody. Serum was assayed for antibody by using an ELISA-based procedure with an immunoblot confirmation (13) , which was kindly performed in Luc Montagnier's laboratory at the Institute Pasteur.
Purine Enzymes. After separation of the peripheral blood over Ficoll/Hypaque, the erythrocyte pellet was washed with phosphate-buffered saline and an extract was made in 50 mM potassium phosphate buffer (pH 7.4) by freeze-thawing four times in dry ice/acetone. The extract was frozen at -70'C until assayed.
ADA and PNP activities were measured using a spectrophotometric assay of uric acid production, which has previously been described (14) . Briefly, for ADA activity, the reaction mixture consisted of 0.79 ml of phosphate buffer, 5 p1L of xanthine oxidase (Sigma), 0.1 ml of 10 mM adenosine, 5 ,.1 ofPNP (Sigma) (diluted 1:20) , and 0.1 ml of a 1:10 dilution of extract. For PNP activity, the reaction mixture was similar except that inosine was used in place of adenosine, PNP was omitted, and the extract was diluted 1:40. The results are expressed as nmol of uric acid produced per hr per mg of hemoglobin. Hemoglobin concentrations were measured using the cyanomethanoglobin method. RESULTS Erythrocyte ADA activity is shown in Fig. 1 erythrocyte ADA. Those individuals at high risk for AIDS could be divided into two groups, depending on whether they had serologic evidence for exposure to the AIDS-related retrovirus. Those who were positive had significantly elevated erythrocyte ADA activity (P < 0.002) while those who were negative had normal activities.
Erythrocyte PNP activity was not significantly elevated compared to heterosexual controls except for the high-risk antibody-positive group, in which PNP was slightly greater than normal (P = 0.04) (Fig. 2) . Also, when the antibody- positive and -negative high-risk individuals were assessed, there was no correlation with PNP activity. Lymphocyte phenotyping and in vitro responses to phytohemagglutinin and pokeweed mitogen are shown in Table 1 . Data were available from all 20 patients with AIDS or ARC, 11 high-risk individuals, and 7 heterosexual controls. The AIDS patients had normal percentages of cells expressing the pan-T-cell marker OKT3 with depressed OKT4 and elevated OKT8. The lymphocyte responses to both PHA and PWM were significantly depressed in the patients with'AIDS (P < 0.02 and P < 0.001, respectively). There were no significant differences between the high-risk group and the healthy heterosexual population for phenotype or in vitro lymphocyte responses to mitogens.
Finally, the purine enzyme activities and the results of the immunological studies are compared among the high-risk groups with high ADA and normal ADA, patients with AIDS/ARC, and healthy heterosexual controls in Table 1 . Though the differences are not statistically significant, the T-cell immunity in those high-risk individuals who were positive for antibody to the AIDS-related retrovirus appears to be more abnormal than that in individuals who are antibody-negative. Also, erythrocyte PNP activity in this small subgroup of high-risk antibody-positive individuals with elevated ADA is elevated relative to that of healthy heterosexual individuals (P = 0.04).
DISCUSSION
We have found an association between AIDS and elevated erythrocyte ADA. This appears to be relatively specific for ADA since the next enzyme in the purine metabolic pathway, PNP, is relatively normal in patients with AIDS. Furthermore, we have found that in individuals who are at high risk for exposure to the AIDS-related retrovirus but are otherwise clinically well, there appears to be a correlation between the presence of antibody to the retrovirus and significantly elevated erythrocyte ADA. There are several possible explanations for the finding of increased ADA in AIDS. One is that this is a nonspecific elevation due to other factors, such as opportunistic or other viral infections, malignancy, or hematologic abnormalities. This is unlikely, since most of the patients with Kaposi sarcoma did not have opportunistic infections and those with opportunistic infections did not have malignancy. Also, we have measured ADA and PNP in children with immunodeficiency disease and disseminated viral infections and have found these enzymes to be normal (data not shown). Furthermore, in the two subgroups of high-risk individuals, the only distinguishing feature between them was the presence or absence of antibody to the AIDSrelated retrovirus. Finally, we measured several hematologic abnormalities in these high-risk individuals including hemoglobin concentrations, erythrocyte counts, and mean corpuscular hemoglobin concentration (data not shown) and could find no differences between those with high ADA activity and those with normal ADA activity.
A second possible explanation for elevated erythrocyte ADA in these patients is that it is a result of the retrovirus infection. The elevated ADA activity could be due to either an alteration in the protein that would change the Km or an increased amount of protein. In any event, these data suggest that the alterations in ADA metabolism occurred in the early bone marrow erythroid cells still capable of synthesizing protein and may be a result of retrovirus infection. It has recently been shown that HTLV-III has trans-activating capability and codes for a trans-activating factor that activates the expression of genes linked to the HTLV-III long terminal repeat (15, 16) . Early work suggests that this protein has structural features similar to other nucleic acid binding proteins. It is possible that trans-acting transcriptional reg- ulatory elements may alter the expression not only of integrated viral genes but also of cellular genes. Presumably, if the AIDS-related retrovirus infects stem cells or early erythroid precursor cells, one mechanism that could explain the selective increase in ADA is a regulatory effect by the trans-activating factor on the promoter region of the ADA gene, resulting in an inappropriately high cellular ADA level. Since it is likely that the AIDS-related retrovirus is capable of infecting cells other than the OKT4-positive cell, this possibility warrants further study.
The immunodeficiency seen in ADA deficiency is clearly a result of that inborn error of metabolism, although the pathogenesis is poorly understood (9) . It is possible, but unlikely, that the increased ADA activity in patients with AIDS is responsible for the immunodeficient state. There is evidence that in patients with AIDS at least one subpopulation of lymphocytes (null cells) also has elevated ADA activity (17) . In fact, in the study of null cell ADA, both ADA and PNP activities were found to be significantly elevated in the null lymphocytes by approximately 30o. T lymphocytes from these patients, however, had normal purine enzyme activity, suggesting that this was not responsible for the T-cell immunodeficiency. Erythrocyte ADA and PNP were not reported.
Elevated erythrocyte ADA activity has been reported in other diseases including Diamond-Blackfan syndrome (18) , congenital hemolytic anemia (19, 20) , short-limbed dwarfism (9) , and reticular dysgenesis (21) . However, erythrocyte ADA activity is not increased in patients with reticulocytosis secondary to nonhereditary hemolytic anemia, in fetal erythrocytes, in erythrocytes from patients receiving steroids, in patients with stress erythropoiesis, or in the syndrome of transient erythroblastopenia of childhood (18) . In patients with some types of leukemia or carcinoma elevated leukocyte or plasma ADA or PNP has been reported with normal erythrocyte activities (22, 23) . Increased serum ADA activity has also been reported in patients with infectious mononucleosis, hepatitis, and hepatocellular jaundice (24, 25) . ADA is normally found in the liver, and serum levels might be expected to increase as a result of tissue damage. The mechanisms for the elevations in these disorders are unknown; however, it is likely that they are distinct from that resulting in elevated ADA in patients with AIDS.
There are several implications of our results that warrant further study. One is that the retrovirus infection has a direct effect on erythrocyte purine metabolism, possibly by an infection of an early erythroid precursor. An understanding of the mechanism for the increased ADA is likely to enhance our knowledge of the molecular biology of the AIDS-related retrovirus. Another implication involves the practical aspect of diagnosis of AIDS or more specifically of infection by the AIDS retrovirus. In the high-risk population, elevated erythrocyte ADA correlated with the presence of antibody to the virus. Longitudinal studies may make it possible to determine whether high-risk patients exist who have elevated ADA without antibody and whether this can be used to detect those individuals who may be infected but have not yet developed a positive antibody titer.
